Prostate cancer is the most prevalent malignancy among Canadian men. While treatments exist, many tumors are resistant, highlighting the urgent need to develop more effective therapies. This project aims to develop new drugs for prostate cancer by inhibiting the Lin28 protein, which increases cancer cells’ growth and resistance to treatments. This will be achieved by […]
Read More